Publications by authors named "P Jenner"

Claim this Profile
A
Apomorphine differentially engages the cAMP and β-arrestin signaling pathways relative to dopamine at human dopamine receptors.
Brittney Yegla, Jonathan Rubin, Mindy Grall, Andrea Formella, Peter Jenner

J Neural Transm (Vienna)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COMT inhibition with entacapone for patients with Parkinson's disease and motor complications: the novelty of continuous infusion.
Peter Jenner, Dag Nyholm

J Neural Transm (Vienna)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Moving to a non-dopaminergic approach for the treatment of OFF fluctuations in Parkinson's disease.
Stuart H Isaacson, Peter Jenner

Clin Park Relat Disord· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Should continuous dopaminergic stimulation be a standard of care in advanced Parkinson's disease?
Z Pirtošek, V Leta, P Jenner, M Vérin

J Neural Transm (Vienna)· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How and why the adenosine A receptor became a target for Parkinson's disease therapy.
Peter Jenner, Tomoyuki Kanda, Akihisa Mori

Int Rev Neurobiol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis